Completed OBSERVATIONAL NCT05761184

Characterization of Serum Proteome in Subjects With Prader Willi Syndrome (PROTEOMARKER) (PROTEOMARKER)

Characterization of Serum Proteome in Subjects Suffering From Prader Willi Syndrome With Different Degrees of Liver Steatosis

Sponsor: Istituto Auxologico Italiano

Conditions Prader-Willi Syndrome

Interventions Serum collection for proteomic analysis

Updated 4 times since 2023 Last updated: Feb 9, 2024 Started: Apr 28, 2022 Primary completion: Oct 28, 2022 Completion: Oct 28, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT05761184, this observational or N/A phase trial focuses on Prader-Willi Syndrome and remains completed. Sponsored by Istituto Auxologico Italiano, it has been updated 4 times since 2022, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Mar 2024 — Jul 2024 [monthly]

Completed
Apr 2023 — Mar 2024 [monthly]

Completed

First recorded

Apr 2022

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Istituto Auxologico Italiano

Data source: Istituto Auxologico Italiano

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Oggebbio, Italy